-
Strategy First! UCLI-ICML Joint Session Lays Foundation for Collaboration
Editor’s note: 01. Confidence, Cooperation, Progress — UCLI-ICML Joint Session Lays Foundation for Collaboration Dr. Ma: The UCLI-ICML joint session has been held four times to date. Ten years ago,…
-
APASL 2023 | Professor Li Jun: Latest Developments in ACLF Early Warning Models, Pioneering with Large-Scale Data from China
Acute-on-Chronic Liver Failure (ACLF) is a complex syndrome characterized by acute deterioration of liver function on the background of chronic liver disease, accompanied by liver and/or extrahepatic organ failure. It poses a significant challenge in internal medicine due to its high short-term mortality rate of 50% to 90%. Early prediction of the risk of ACLF…
-
ID Week Commentary | Dr. Junyan Qu: Real-world Efficacy Comparison of CT vs. CZA in Treating MDR-PA Infections
Dr. Junyan Qu Infectious Diseases Center, West China Hospital of Sichuan University Research Introduction A multicenter, observational study to compare the effectiveness of eftazidim vibactam versus eftolozane azobactam for multidrug-resistant…
-
Second-Line Treatment for Advanced HCC – Interpretation of the “CSCO Primary HCC Diagnosis and Treatment Guidelines (2022 Edition)
Targeted Therapies 1. Regorafenib The RESORCE study solidified the position of regorafenib as a second-line treatment for advanced HCC. Compared to placebo, regorafenib significantly extended the median overall survival (mOS)…
-
ILCA 2023 | Molecular typing based on fatty acid degradation metabolism helps in achieving precision treatment for liver cancer.
Primary liver cancer is currently the 4th most common malignant tumor and the 2nd leading cause of tumor-related death in China. 75%~85% of these cases are Hepatocellular carcinoma (HCC), posing a serious threat to the health and lives of Chinese citizens. In recent years, with the progress in traditional therapies like surgery, intervention, radiation, targeted…
-
ILCA Expert Interview | Moving Forward Together! The Development and Prospects of Multidisciplinary Comprehensive Treatment of Liver Cancer
Primary liver cancer is one of the common malignant tumors worldwide. With the development of modern biomedical technology, clinical surgical techniques, and minimally invasive treatment techniques, the surgical treatment level of liver cancer has made significant progress. At the recently concluded global academic event in the field of liver cancer – the 17th Annual Meeting…
-
Youth Forum of APACC 2023 | (5R)-5-hydroxytriptolide Holds Promise for HIV immunological Non-responders Receiving ART
Hello everyone, I’m Xiaosheng Liu , a graduate student from Professor Taisheng Li’s team of Peking Union Medical College Hospital, China. My primary research focus is on the mechanisms underlying…
-
Dr. Peter Reiss: Moving Towards the Fourth “90” Goal – Strategies for Improving the Quality of Life and Management of HIV/AIDS Patients
Dr. Peter Reiss Honorary Dr. at the Amsterdam University Medical Center, University of Amsterdam, former President of the European AIDS Clinical Society (EACS) (2008-2012), former Regional Director for Europe and…
Connecting Medical Expertise through Media